These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 21078493)

  • 21. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.
    Gilliam BE; Ombrello AK; Burlingame RW; Pepmueller PH; Moore TL
    Semin Arthritis Rheum; 2012 Jun; 41(6):840-8. PubMed ID: 22177108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD; Patwardhan MM; Ghosh K
    Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies.
    Gutiérrez-Adrianzén OA; Koutouzov S; Mota RM; das Chagas Medeiros MM; Bach JF; de Holanda Campos H
    J Rheumatol; 2006 Aug; 33(8):1538-44. PubMed ID: 16783863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis.
    Moroni G; Radice A; Giammarresi G; Quaglini S; Gallelli B; Leoni A; Li Vecchi M; Messa P; Sinico RA
    Ann Rheum Dis; 2009 Feb; 68(2):234-7. PubMed ID: 18718989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-C1q antibodies in juvenile-onset systemic lupus erythematosus.
    Jesus AA; Silva CA; Carneiro-Sampaio M; Sheinberg M; Mangueira CL; Marie SK; Liphaus BL
    Ann N Y Acad Sci; 2009 Sep; 1173():235-8. PubMed ID: 19758156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
    Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
    Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of the nucleosome in the physiopathology of systemic lupus erythematosus].
    Amoura Z; Piette JC
    Ann Med Interne (Paris); 2003 Feb; 154(1):25-32. PubMed ID: 12746656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis.
    Hung WT; Chen YM; Lan JL; Chen HH; Chen YH; Chen DY; Hsieh CW; Wen MC
    Lupus; 2011 Nov; 20(13):1404-10. PubMed ID: 21946514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q.
    Bengtsson A; Nezlin R; Shoenfeld Y; Sturfelt G
    J Autoimmun; 1999 Aug; 13(1):111-9. PubMed ID: 10441175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-dsDNA antibody testing by Farr and ELISA techniques is not equivalent.
    Neogi T; Gladman DD; Ibanez D; Urowitz M
    J Rheumatol; 2006 Sep; 33(9):1785-8. PubMed ID: 16924691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis.
    Yang XW; Tan Y; Yu F; Zhao MH
    Nephrol Dial Transplant; 2012 Sep; 27(9):3552-9. PubMed ID: 22700716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-C1q, anti-chromatin/nucleosome, and anti-dsDNA antibodies in juvenile systemic lupus erythematosus patients.
    Jesus AA; Campos LM; Liphaus BL; Carneiro-Sampaio M; Mangueira CL; Rosseto EA; Silva CA; Scheinberg M
    Rev Bras Reumatol; 2012 Dec; 52(6):976-81. PubMed ID: 23223707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-C1q antibody as a marker of disease activity in systemic lupus erythematosus.
    Kumar A; Gupta R; Varghese T; Pande RM; Singal VK; Garg OP
    Indian J Med Res; 1999 Dec; 110():190-3. PubMed ID: 10701298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
    Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
    Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.
    Zandman-Goddard G; Blank M; Langevitz P; Slutsky L; Pras M; Levy Y; Shovman O; Witte T; Doria A; Rovensky J; Shoenfeld Y
    Ann Rheum Dis; 2005 Dec; 64(12):1698-702. PubMed ID: 16014675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Capacity to predict a recurrence of lupus erythematosus using double-stranded anti-DNA antibodies and Farr technique].
    Massardo L; Martínez ME; Pérez R; Ramírez V; Foradori A; González A; Radrigán F; Gutiérrez F; Jacobelli S
    Rev Med Chil; 1999 Apr; 127(4):411-20. PubMed ID: 10451606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody clustering helps refine lupus prognosis.
    Kessel A; Rosner I; Halasz K; Grushko G; Shoenfeld Y; Paran D; Toubi E
    Semin Arthritis Rheum; 2009 Aug; 39(1):66-70. PubMed ID: 18538829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
    Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
    Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.